Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
bivirkning af erythropoietin |
Causative agent |
False |
Erythropoietin |
Inferred relationship |
Some |
1 |
Epoetin alfa adverse reaction |
Causative agent |
False |
Erythropoietin |
Inferred relationship |
Some |
|
Epoetin beta adverse reaction |
Causative agent |
False |
Erythropoietin |
Inferred relationship |
Some |
|
Erythropoietin measurement |
Has measured component |
False |
Erythropoietin |
Inferred relationship |
Some |
|
behandling med erythropoietin |
Direct substance |
False |
Erythropoietin |
Inferred relationship |
Some |
1 |
Serum erythropoetin measurement (procedure) |
Has measured component |
False |
Erythropoietin |
Inferred relationship |
Some |
|
Erythropoietin measurement |
Component |
True |
Erythropoietin |
Inferred relationship |
Some |
1 |
Serum erythropoetin measurement (procedure) |
Component |
False |
Erythropoietin |
Inferred relationship |
Some |
2 |
Darbepoetin alfa |
Is a |
False |
Erythropoietin |
Inferred relationship |
Some |
|
Epoetin alfa (substance) |
Is a |
False |
Erythropoietin |
Inferred relationship |
Some |
|
erythropoietinpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythropoietin |
Inferred relationship |
Some |
1 |
allergi over for erythropoietin |
Causative agent |
False |
Erythropoietin |
Inferred relationship |
Some |
|
Allergy to epoetin beta |
Causative agent |
False |
Erythropoietin |
Inferred relationship |
Some |
|
overdosis af erythropoietin |
Causative agent |
False |
Erythropoietin |
Inferred relationship |
Some |
1 |
Product containing epoetin beta (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythropoietin |
Inferred relationship |
Some |
|
epoetin beta 50.000 IE pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythropoietin |
Inferred relationship |
Some |
|
epoetin beta 100.000 IE pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythropoietin |
Inferred relationship |
Some |
|
epoetin beta 10.000 IE pulver og solvent til injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythropoietin |
Inferred relationship |
Some |
|
epoetin beta 20.000 IE pulver og solvent til injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythropoietin |
Inferred relationship |
Some |
|
epoetin beta 500 IE pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythropoietin |
Inferred relationship |
Some |
|
epoetin beta 500 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythropoietin |
Inferred relationship |
Some |
|
epoetin beta 1000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythropoietin |
Inferred relationship |
Some |
|
epoetin beta 2000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythropoietin |
Inferred relationship |
Some |
|
epoetin beta 3000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythropoietin |
Inferred relationship |
Some |
|
epoetin beta 5000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythropoietin |
Inferred relationship |
Some |
|
epoetin beta 10.000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythropoietin |
Inferred relationship |
Some |
|
epoetin beta 60.000 IE pulver og solvent til injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythropoietin |
Inferred relationship |
Some |
|
epoetin beta 6000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythropoietin |
Inferred relationship |
Some |
|
epoetin beta 4000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythropoietin |
Inferred relationship |
Some |
|
epoetin beta 20.000 IE/ml injektionsvæske, opløsningi fyldt injektionssprøjte a 0,6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythropoietin |
Inferred relationship |
Some |
|
epoetin beta 30.000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythropoietin |
Inferred relationship |
Some |
|
Epoetin beta (substance) |
Is a |
False |
Erythropoietin |
Inferred relationship |
Some |
|
Epoetin delta (substance) |
Is a |
False |
Erythropoietin |
Inferred relationship |
Some |
|
Epoetin zeta (substance) |
Is a |
False |
Erythropoietin |
Inferred relationship |
Some |
|
Erythropoietin resistance in anemia of chronic kidney disease (disorder) |
Associated with |
True |
Erythropoietin |
Inferred relationship |
Some |
1 |
behandling med erythropoietin |
Direct substance |
False |
Erythropoietin |
Inferred relationship |
Some |
1 |
allergi over for erythropoietin |
Causative agent |
False |
Erythropoietin |
Inferred relationship |
Some |
1 |
Epoetin theta (substance) |
Is a |
False |
Erythropoietin |
Inferred relationship |
Some |
|
Product containing only erythropoietin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythropoietin |
Inferred relationship |
Some |
1 |
Methoxy polyethylene glycol-epoetin beta (substance) |
Is a |
False |
Erythropoietin |
Inferred relationship |
Some |
|
Antibody mediated acquired pure red cell aplasia caused by erythropoiesis stimulating agent (disorder) |
Causative agent |
True |
Erythropoietin |
Inferred relationship |
Some |
1 |
Serum erythropoetin measurement (procedure) |
Component |
True |
Erythropoietin |
Inferred relationship |
Some |
1 |